Get started
Author

Keira Joann Herr

Observed names: *Keira Joann Herr, Herr, Keira Joann, K Herr, Keira Herr, Keira J. Herr
Observed institutions: Agency for Science, Technology and Research, Scripps Research Institute, National University of Singapore, Johnson & Johnson (Singapore), Duke-NUS Medical School, Institute of Molecular and Cell Biology
ORCID: 0000-0003-1322-6407
Observed ORCID: 0000-0003-1322-6407
OpenAlex ID: A5079947621
Extracellular matrix scaffolding guides lumen elongation by inducing anisotropic intercellular mechanical tension
2016 · Qiushi Li, Yue Zhang, et al. · Nature Cell Biology · 73
Stereotyped fetal brain disorganization is induced by hypoxia and requires lysophosphatidic acid receptor 1 (LPA 1 ) signaling
2011 · Keira Joann Herr, Deron R. Herr, et al. · Proceedings of the National Academy of Sciences · 55
Loss of α-catenin elicits a cholestatic response and impairs liver regeneration
2014 · Keira Joann Herr, Ying-hung Nicole Tsang, et al. · Scientific Reports · 44
PDF
18F-FDG as an inflammation biomarker for imaging dengue virus infection and treatment response
2017 · Ann-Marie Chacko, Satoru Watanabe, et al. · JCI Insight · 35
PDF
The growing burden of generalized myasthenia gravis: a population-based retrospective cohort study in Taiwan
2023 · Keira Joann Herr, Shih-Pei Shen, et al. · Frontiers in Neurology · 21
A Taiwanese study on real-world evidence with vortioxetine in patients with major depression in Asia (TREVIDA)
2021 · Yen Kuang Yang, Cheng-Sheng Chen, et al. · Current Medical Research and Opinion · 18
Cognitive dysfunction in Malaysian patients with major depressive disorder: A subgroup analysis of a multicountry, cross‐sectional study
2018 · Nor Zuraida Zainal, Pranab Kalita, et al. · Asia-Pacific Psychiatry · 15
A real‐world prospective observational study of eptinezumab in Asian patients with migraine
2024 · Yi Jing Zhao, Jonathan Jia Yuan Ong, et al. · Headache The Journal of Head and Face Pain · 12
A Delphi consensus on clinical features, diagnosis and treatment of major depressive disorder patients with anhedonia amongst psychiatrists in the Asia-Pacific
2024 · Calvin Cheng, Keira Herr, et al. · Frontiers in Psychiatry · 12
Guselkumab in East Asians With Moderate‐to‐Severe Ulcerative Colitis: Subgroup Analysis of the QUASAR Induction and Maintenance Studies
2025 · Baili Chen, Byong Duk Ye, et al. · Journal of Gastroenterology and Hepatology · 7
PDF
A comparison of real-world effectiveness of vortioxetine along the treatment algorithm for major depressive disorder
2022 · Rohini Bose, Syed Usman Hamdani, et al. · Current Medical Research and Opinion · 7
Anhedonia in Major Depressive Disorder: Prevalence and Treatment Expectations and Satisfaction with Treatment Goals Among Patients and Physicians in Asia-Pacific
2024 · Keira Herr, Michael Berk, et al. · Neuropsychiatric Disease and Treatment · 6
PDF
Healthcare resource utilization and costs associated with generalized myasthenia gravis: a retrospective matched cohort study using the National Health Insurance Research Database in Taiwan
2023 · Shih-Pei Shen, Keira Joann Herr, et al. · Frontiers in Neurology · 6
Understanding anhedonia in major depressive disorder in Japan: epidemiology and unmet needs from patients’ and physicians’ perspectives
2025 · Mami Kasahara-Kiritani, Tadafumi Kato, et al. · BMC Psychiatry · 4
PDF
The Impact of Anhedonia on the Disease Burden of Major Depressive Disorder in the Asia–Pacific Region: A Cross‐Sectional Real‐World Study
2025 · Keira Herr, Michael Berk, et al. · Neuropsychopharmacology Reports · 4
PDF
A Real-life Study of Brexpiprazole as an Adjunctive Treatment for Major Depressive Disorder in Asian Patients in Singapore (BADA)
2024 · Yee Ming Mok, Pei Lin Lynnette Tan, et al. · Clinical Psychopharmacology and Neuroscience · 4
PDF
Humanistic burden and medical care patterns of real-world patients with myasthenia gravis in Japan
2025 · Mami Kasahara-Kiritani, Yosuke Saga, et al. · Frontiers in Neurology · 3
PDF
Prevalence and burden of anhedonia among patients with major depressive disorder in South Korea: A cross-sectional, observational study
2025 · Bolam Lee, YoungDoe Kim, et al. · PLoS ONE · 2
PDF
Clinical Status, Treatment, and Disease Burden of Generalised Myasthenia Gravis in the Asia–Pacific
2025 · Thomas Webb, Mami Kasahara-Kiritani, et al. · Neurology and Therapy · 2
PDF
Epidemiology and Burden of Disease of Major Depressive Disorder (mdd) With Anhedonia in Asia Pacific
2025 · *Keira Joann Herr, Michael Berk, et al. · The International Journal of Neuropsychopharmacology · 2
Efficacy and safety of subcutaneous guselkumab in East Asian participants with moderately to severely active Crohn’s disease: subgroup analysis of the Phase 3 GRAVITI study
2026 · Wenjia Liu, Hong Guo, et al. · Intestinal Research · 1
PDF
Symptomatic improvement with intravenous guselkumab induction therapy is observed early in patients with moderately to severely active Ulcerative colitis: post-hoc analysis of QUASAR
2026 · A Dignaß, F Hirai, et al. · Zeitschrift für Gastroenterologie
Guselkumab efficacy and safety in East Asian participants with moderately to severely active Crohn’s disease: subgroup analysis of the phase 3 GALAXI 2 and GALAXI 3 trials
2026 · Hiroshi Nakase, Baili Chen, et al. · Intestinal Research
PDF
Mo1518 SYMPTOMATIC IMPROVEMENT WITH INTRAVENOUS GUSELKUMAB INDUCTION THERAPY IS OBSERVED EARLY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: POST-HOC ANALYSIS OF QUASAR
2026 · Axel Dignass, Fumihito Hirai, et al. · Gastrointestinal Endoscopy
Mo1518 SYMPTOMATIC IMPROVEMENT WITH INTRAVENOUS GUSELKUMAB INDUCTION THERAPY IS OBSERVED EARLY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: POST-HOC ANALYSIS OF QUASAR
2026 · Axel Dignass, Fumihito Hirai, et al. · Gastroenterology
Works count: 33
Citation count: 333
H-index: 9
I10-index: 9
Year
Topic
Type